Clinical Trial Update: A Study of CCCTC-binding Factor (CTCF) in Infantile Hemangiomas

View source ↗

Summary

A Yale University-sponsored clinical trial studying CTCF in infantile hemangiomas has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infantile Hemangioma

Snippet

Sponsor: Yale University | Conditions: Hemangioma | Status: WITHDRAWN